Article
Recombinant hirudin: kinetic mechanism for the inhibition of human thrombin.
Protein engineering - 1 Feb 1991
Stone S R, Hofsteenge J
Abstract excerpt
Recombinant hirudin variant-2(Lys47), was found to be a competitive inhibitor of human alpha-thrombin with respect to peptidyl p-nitroanilide substrates. These results contrast with those of Degryse and coworkers that suggest that recombinant hirudin variant-2(Lys47) inhibited thrombin by a noncompetitive mechanism [Degryse et al. (1989) Protein Engng, 2, 459-465]. gamma-Thrombin, which can arise from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
